Tag: Silo Pharma - Page 7 - Psychedelic Alpha

Read more about the article Silo Pharma, Inc. Launches Scientific Advisory Board with Appointment of Dr. Matthew Johnson of John Hopkins University

Silo Pharma, Inc. Launches Scientific Advisory Board with Appointment of Dr. Matthew Johnson of John Hopkins University

Post published:November 9, 2020
Post category:Press Release

Read more about the article Silo Pharma, Inc. (SILO) Announces Successful Uplisting To the OTCQB Venture Market

Silo Pharma, Inc. (SILO) Announces Successful Uplisting To the OTCQB Venture Market

Post published:October 14, 2020
Post category:Press Release

Read more about the article Silo Pharma, Inc. Enters into Option Agreement with University of Maryland Baltimore for Central Nervous System-Homing Peptides

Silo Pharma, Inc. Enters into Option Agreement with University of Maryland Baltimore for Central Nervous System-Homing Peptides

Post published:October 13, 2020
Post category:Press Release

Read more about the article Silo Pharma, Inc. Expands Board with Appointment of Dr. Kevin Muñoz MD; Announces Application to Uplist to OTCQB Market

Silo Pharma, Inc. Expands Board with Appointment of Dr. Kevin Muñoz MD; Announces Application to Uplist to OTCQB Market

Post published:October 6, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.